Team |
Mitchell Finer, PhD
Mitchell Finer, PhD

Mitchell Finer, PhD

Chief Executive Officer

Mitch heads executive leadership at Life Edit Therapeutics. He has more than three decades of experience developing cell and gene therapy products and companies and is also Chief Scientific Officer at ElevateBio and President of ElevateBio BaseCamp. 

Previously, he founded and was CEO of both Oncorus and CODA Biotherapeutics, and is currently on the board of these and other MPM Capital portfolio companies, including Semma Therapeutics and TCR2 Therapeutics. 

Prior to this, Mitch served as Chief Science Officer of bluebird bio, CEO of Intracel Corporation and Genteric, Vice President of Research for Cell Genesys and the Gencell division of Aventis Pharma (now Sanofi), and Senior Vice President of Development at Novacell (now Viacyte). He also co-founded the retinal disease gene therapy company Avalanche Biotechnologies (now Adverum Biotechnologies) and is currently on its board of directors.

Mitch has been named inventor on 15 issued U.S. patents. He received his PhD in Biochemistry and Molecular Biology from Harvard University and has a BS in Biochemistry and Microbiology from the University of California at Berkeley.

Connect with
Mitchell
https://www.linkedin.com/in/mitchellhfiner/

Visionary science, driven by visionary values.

Our Mission

To rewrite the future by curing disease, making any edit, anywhere.

Our Vision

To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.

Our Values

We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.